Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
66694 studies found for:    pharmacology
Show Display Options
RSS Create an RSS feed from your search for:
pharmacology
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Robotic Pharmacological Anesthesia System for Elective Cardiac Surgery
Condition: Cardiac Surgery
Intervention: Device: Test of pharmacologic anesthesia robot (labVIEW® software)
2 Completed Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: electrical cardioversion;   Drug: propafenone
3 Completed Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]
Condition: Healthy
Interventions: Drug: MDA;   Drug: Placebo
4 Completed A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects
Condition: Clinical Pharmacology
Interventions: Drug: TAK-233;   Drug: Placebo
5 Completed Abuse Liability and Human Pharmacology of Mephedrone
Condition: Amphetamine-Related Disorders
Interventions: Drug: Mephedrone;   Drug: 3,4-methylenedioxymethamphetamine;   Drug: Placebo
6 Completed Tenofovir Pharmacology in Older HIV Infected Individuals
Conditions: HIV;   Aging
Intervention: Drug: iohexol
7 Completed Pharmacological Aids for Interactive Smoking Cessation
Condition: Smoking Cessation
Interventions: Behavioral: Smokefree Partners: 21 Days to Freedom;   Other: Wait-List Control
8 Completed Pilot Study of Pharmacology of Paracetamol Administered Per-oral Mucosa
Condition: Healthy
Interventions: Drug: Kinetics of plasma concentrations of paracetamol;   Drug: Placebo
9 Withdrawn Pharmacology Study of Aerosolized Liposomal
Conditions: Lung Diseases;   Cancer
Intervention: Drug: L9NC: Liposomal 9-Nitro-20 (S)-Camptothecin
10 Completed
Has Results
Study of Pharmacology of 17-OHPC in Pregnancy
Condition: Pregnancy
Interventions: Drug: 17-OHPC;   Procedure: Blood Draws
11 Withdrawn Pharmacology of Exenatide in Pediatric Sepsis
Conditions: Septic Shock;   Inflammation;   Glucose Homeostasis;   Organ Dysfunction;   Health-related Quality of Life
Interventions: Drug: Exenatide;   Drug: Exenatide vehicle
12 Recruiting Antiviral Pharmacology and Adherence in Drug Users
Conditions: HEPATITIS C;   Virus, Human Immunodeficiency
Interventions: Behavioral: Directly Observed Therapy;   Behavioral: Wirelessly Observed Therapy
13 Completed A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacology of ONO-4474 in Healthy Volunteers
Condition: Osteoarthritis
Interventions: Drug: ONO-4474 Part A1;   Drug: Placebo Part A1;   Drug: ONO-4474 Part A2;   Drug: Placebo Part A2;   Drug: ONO-4474 Part B;   Drug: Placebo Part B;   Drug: ONO-4474 Part C;   Drug: Placebo Part C;   Drug: ONO-4474 Part D;   Drug: Placebo Part D
14 Completed Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment
Condition: Rheumatoid Arthritis
Intervention: Drug: MRA(Tocilizumab)
15 Completed Alefacept Mechanism of Action in Psoriasis
Condition: Psoriasis
Intervention: Drug: Mechanism of action of alefacept
16 Completed Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and the Lung Availability of CHF 5993 in Healthy Volunteers
Condition: COPD
Interventions: Drug: CHF 5993 100/6/12,5 pMDI;   Drug: CHF 5993 100/6/12,5 DPI Test 1;   Drug: CHF 5993 100/6/12,5 DPI Test 2;   Drug: CHF 5993 100/6/12,5 pMDI replicate;   Drug: CHF 5993 100/6/12,5 pMDI with Valved Holding Chamber
17 Completed A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin
Conditions: Hypercholesterolemia;   Hyperlipoproteinemia
Interventions: Drug: Pravastatin;   Drug: Lifibrol
18 Completed Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients
Condition: Asthma
Interventions: Drug: Test treatments CHF 1535 100/6 pMDI (Foster®) TEST1;   Drug: CHF 1535 100/6 pMDI (Foster®) using AeroChamber Plus™ (TEST 2).;   Drug: BDP pMDI 100 µg (Qvar®) plus formoterol fumarate pMDI 6 µg (Atimos®) (REF);   Drug: CHF 1535 100/6 pMDI (Foster®) (CTR)
19 Completed Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma
Conditions: Advanced Solid Tumors;   Lymphomas
Intervention: Drug: Camptothecin-20-O-Propionate Hydrate (CZ48)
20 Unknown  Behavioral Pharmacology Associated With Cigar Smoking
Condition: Cigar Smoking
Intervention: Other: Smoking topography

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.